TRANSCATHETER HEART VALVE THROMBOSIS

Clinical trials for TRANSCATHETER HEART VALVE THROMBOSIS explained in plain language.

Never miss a new study

Get alerted when new TRANSCATHETER HEART VALVE THROMBOSIS trials appear

Sign up with your email to follow new studies for TRANSCATHETER HEART VALVE THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Ancient gout drug may protect modern heart valves

Disease control Not yet recruiting

This study is testing whether a low daily dose of colchicine, an anti-inflammatory drug, can prevent blood clots from forming on new artificial heart valves after TAVR surgery. About 116 older adults (ages 60-85) who have had successful TAVR will be randomly assigned to take colc…

Matched conditions: TRANSCATHETER HEART VALVE THROMBOSIS

Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

TRANSCATHETER HEART VALVE THROMBOSIS

Get alerted when new TRANSCATHETER HEART VALVE THROMBOSIS trials appear

Ancient gout drug may protect modern heart valves